Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Eloxx Pharmaceuticals Reports $4.5 Million Net Loss and $62 Million Cash Position for Q2 2026
Eloxx Pharmaceuticals Reports $3.8 Million Net Loss in Q1 2026, Sees Surge in Operating Expenses
Eloxx Pharmaceuticals Files Annual Report, Reports Increased Net Loss and Financial Challenges